These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Microbicidal actives with virucidal efficacy against SARS-CoV-2. Ijaz MK; Whitehead K; Srinivasan V; McKinney J; Rubino JR; Ripley M; Jones C; Nims RW; Charlesworth B Am J Infect Control; 2020 Aug; 48(8):972-973. PubMed ID: 32461067 [No Abstract] [Full Text] [Related]
28. Emergency response to the outbreak of COVID-19: the Korean case. Ha KM Microbes Infect; 2020; 22(4-5):159-161. PubMed ID: 32278074 [TBL] [Abstract][Full Text] [Related]
29. Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring. Krishan K; Kanchan T Acta Biomed; 2020 Sep; 91(3):e2020023. PubMed ID: 32921745 [TBL] [Abstract][Full Text] [Related]
31. In the fight against the new coronavirus outbreak, we must also struggle with human bias. Gonçalves-Sá J Nat Med; 2020 Mar; 26(3):305. PubMed ID: 32152585 [TBL] [Abstract][Full Text] [Related]
32. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria? Sargin G; Yavaşoğlu Sİ; Yavasoglu I Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306 [No Abstract] [Full Text] [Related]
33. Lessons from the Italian COVID-19 frontline. Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392 [No Abstract] [Full Text] [Related]
35. Pre-exposure prophylaxis during the SARS-CoV-2 pandemic: can PrEP prevent COVID-19-related symptoms? Fernandes DE; Ferreira PRA; Mastroianni Kirsztajn G Epidemiol Infect; 2020 Sep; 148():e231. PubMed ID: 32981567 [TBL] [Abstract][Full Text] [Related]
36. Tracking a Vaccine and Developing Therapeutics for COVID-19. Gould KA Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266 [No Abstract] [Full Text] [Related]
37. Protection and disinfection policies against SARS-CoV-2 (COVID-19). Fathizadeh H; Maroufi P; Momen-Heravi M; Dao S; Köse Ş; Ganbarov K; Pagliano P; Esposito S; Kafil HS Infez Med; 2020 Ahead of print Jun 1; 28(2):185-191. PubMed ID: 32275260 [TBL] [Abstract][Full Text] [Related]
38. Targeting Proteases for Treating COVID-19. Luan B; Huynh T; Cheng X; Lan G; Wang HR J Proteome Res; 2020 Nov; 19(11):4316-4326. PubMed ID: 33090793 [TBL] [Abstract][Full Text] [Related]
39. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL Froggatt HM; Heaton BE; Heaton NS J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534 [TBL] [Abstract][Full Text] [Related]
40. Science in the Wake of the Pandemic: How Will COVID-19 Change the Way We Do Research? Mol Cell; 2020 Jul; 79(1):9-10. PubMed ID: 32619472 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]